Bioregenx (BRGX) Return on Capital Employed (2023 - 2026)

Bioregenx's Return on Capital Employed history runs 4 years deep, the most recent figure standing at 30.47% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 57391.0% year-over-year to 30.47%; the TTM figure through Mar 2026 stood at 30.47% (down 57391.0% YoY), while the FY2025 annual figure was 34.49%, down 73818.0% from the prior year.
• Return on Capital Employed was 30.47% for Q1 2026 at Bioregenx, down from 37.96% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 1771.56% in Q3 2023 to a low of 1841.56% in Q2 2023.
• Historically, Return on Capital Employed has averaged 50.6% across 4 years, with a median of 30.47% in 2026.
• Biggest YoY gain for Return on Capital Employed was 179573 bps in 2024; the steepest drop was 180458 bps in 2024.
• A 4-year view of Return on Capital Employed shows it stood at 145.84% in 2023, then sank by 394 bps to 429.35% in 2024, then jumped by 109 bps to 37.96% in 2025, then slipped by 20 bps to 30.47% in 2026.
• The last three Return on Capital Employed figures came in at 30.47% (Q1 2026), 37.96% (Q4 2025), and 671.26% (Q3 2025), per Business Quant data.